Question 1

What is UnitedHealth Group's P/E ratio?

Accepted Answer

UnitedHealth Group (UNH) P/E ratio is 27.7× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for UnitedHealth Group?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For UnitedHealth Group specifically, the relevant sector benchmark is the current sector median of 24.2×.

Question 5

Is UnitedHealth Group's P/E ratio high or low?

Accepted Answer

UnitedHealth Group's P/E ratio of 27.7× is above its own 5-year average of 24.8× and above the sector median of 24.2×. That places the current reading at the 63th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is UnitedHealth Group's historical P/E ratio range?

Accepted Answer

In the available daily series, UnitedHealth Group (UNH) P/E ratio has ranged from a low of 7.6× in 2010 to a high of 40.6× in 2024. The 5-year average is 24.8× and the 5-year median is 24.5×.

Question 7

What was UnitedHealth Group's P/E ratio in 2025?

Accepted Answer

UnitedHealth Group (UNH) P/E ratio at the end of 2025 was 24.9×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does UnitedHealth Group's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$300B	$12.1B	24.9×	-7.6×	Dec 31, 2025
2024	$469B	$14.4B	32.6×	+10.3×	Dec 31, 2024
2023	$498B	$22.4B	22.3×	-2.3×	Dec 31, 2023
2022	$495B	$20.1B	24.6×	-2.7×	Dec 31, 2022
2021	$473B	$17.3B	27.3×	+5.8×	Dec 31, 2021
2020	$332B	$15.4B	21.5×	+1.4×	Dec 31, 2020
2019	$279B	$13.8B	20.1×	+0.2×	Dec 31, 2019
2018	$239B	$12B	20.0×	-0.3×	Dec 31, 2018
2017	$214B	$10.6B	20.2×	-1.5×	Dec 31, 2017
2016	$152B	$7.02B	21.7×	+2.4×	Dec 31, 2016
2015	$112B	$5.81B	19.3×	+2.1×	Dec 31, 2015
2014	$96.4B	$5.62B	17.2×	+3.9×	Dec 31, 2014
2013	$74.4B	$5.63B	13.2×	+3.2×	Dec 31, 2013
2012	$55.3B	$5.53B	10.0×	-0.4×	Dec 31, 2012
2011	$53.6B	$5.14B	10.4×	+1.9×	Dec 31, 2011
2010	$39.5B	$4.63B	8.5×	-0.7×	Dec 31, 2010
2009	$35.1B	$3.82B	9.2×	-1.5×	Dec 31, 2009
2008	$31.8B	$2.98B	10.7×	-5.2×	Dec 31, 2008
2007	$74.1B	$4.65B	15.9×	-1.4×	Dec 31, 2007
2006	$72.2B	$4.16B	17.4×	-7.5×	Dec 31, 2006
2005	$79B	$3.18B	24.8×	+2.6×	Dec 31, 2005
2004	$57.4B	$2.59B	22.2×	+3.4×	Dec 31, 2004
2003	$34.2B	$1.83B	18.8×	+0.1×	Dec 31, 2003
2002	$25.2B	$1.35B	18.7×	—	Dec 31, 2002


Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
Henry Schein (HSIC)	21.0×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
Elevance Health (ELV)	17.0×
HCA Healthcare (HCA)	15.8×
AstraZeneca (AZN)	14.7×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for UnitedHealth Group (UNH) 2002-2026

P/E Ratio daily chart for UnitedHealth Group (UNH)

Historical P/E Ratio for UnitedHealth Group (UNH) from 2002 to 2025

About P/E Ratio at UnitedHealth Group (UNH)

UnitedHealth Group P/E Ratio by Year

UnitedHealth Group P/E Ratio 2025: 24.9×

UnitedHealth Group P/E Ratio 2024: 32.6×

UnitedHealth Group P/E Ratio 2023: 22.3×

UnitedHealth Group P/E Ratio 2022: 24.6×

UnitedHealth Group P/E Ratio 2021: 27.3×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

UnitedHealth Group (UNH) Key Financials